Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Effect of Oral Lubrication on Appetite, Food Intake and Salivary Biomarkers in Protein Beverages (LubSat)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04868461
Recruitment Status : Recruiting
First Posted : May 3, 2021
Last Update Posted : May 3, 2021
Sponsor:
Information provided by (Responsible Party):
Anwesha Sarkar, University of Leeds

Brief Summary:
The main aim of this study is to elucidate the influence of protein beverages differing in their lubrication properties (low/medium/high lubricating) and control (water) on satiety and satiation.

Condition or disease Intervention/treatment Phase
Appetitive Behavior Dietary Supplement: Unheated Whey Protein (UWP) beverage Dietary Supplement: Heated Whey Protein (HWP) beverage Dietary Supplement: Casein (Cas) beverage Dietary Supplement: Water Not Applicable

Detailed Description:

The researchers propose an acute, randomized cross-over study that compares three types of protein beverages differing in their lubricating properties, i.e. one with low lubricating properties made using sodium caseinate, one with medium lubricating properties made by whey protein, and the third one with high lubricating properties made by heated whey protein. All three beverages contain added banana flavour and non-nutritive sweetener. Water acts as a control and has the same flavour and sweetness to match those of the protein beverages.

Participants are asked to come to the laboratory on four occasions. Before participating, each participant is screened for eligibility criteria using an online health screening questionnaire and Three Factors Eating Questionnaire. Participants are offered one of the four treatments (water or either of the three protein beverages), the order of which is randomized and counterbalanced.

Participants are instructed to fast for 11 hours and to restrict from drinking alcohol for 24 hours before each session. Each session lasts 1.5 hours (8.40 am until 10.10 pm). In the first session, weight and height are measured. Participants then provide baseline (- 5 min) appetite ratings on a 100 mm visual analogue scale (VAS). After that they are given the preload - either protein beverages differing in their lubricating properties or water. Then, participants are asked to rate their appetite on a 100-mm VAS every 10 minutes for the next 30 minutes. Ad libitum food is offered as breakfast after 30 min after ingesting the preload and the last VAS is taken. Saliva is taken three times during each session before preload, after preload consumption and before ad libitum breakfast.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 34 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Intervention Model Description: Tightly controlled cross-over study design with four arms.
Masking: Single (Participant)
Masking Description: This is a single-blind study i.e. participants do not know the real purpose of the study. They are given a cover story. They are told about the real purpose of the study at the completion of this.
Primary Purpose: Prevention
Official Title: Effects of Protein Beverages Differing in Their Lubricating Properties on Appetite Control, Subsequent Food Intake and Salivary Biomarkers
Actual Study Start Date : April 13, 2021
Estimated Primary Completion Date : October 31, 2021
Estimated Study Completion Date : December 20, 2021

Resource links provided by the National Library of Medicine

Drug Information available for: Casein

Arm Intervention/treatment
Active Comparator: Unheated whey protein (UWP)
Participants are given a preload of 200 mL of unheated whey protein (UWP) in the morning, on a fasting state. After 30 minutes after the preload, participants are given ad libitum breakfast. They are asked to eat "as much or as little as they want, until they feel comfortably full".
Dietary Supplement: Unheated Whey Protein (UWP) beverage
The preload is made from whey protein powder. The energy load of the preload is 119.7 kcal and has banana flavor and sweetener.

Active Comparator: Heated whey protein (HWP)
Participants are given a preload of 200 mL of heated whey protein (HWP) in the morning, on a fasting state. After 30 minutes after the preload, participants are given ad libitum breakfast. They are asked to eat "as much or as little as they want, until they feel comfortably full".
Dietary Supplement: Heated Whey Protein (HWP) beverage
The preload is made from whey protein powder of 95% and it is heated for a certain amount of time. The energy load of the preload is 119.7 kcal and has banana flavor and sweetener.

Active Comparator: Casein (Cas)
Participants are given a preload of 200 mL of Casein (Cas) in the morning, on a fasting state. After 30 minutes after the preload, participants are given ad libitum breakfast. They are asked to eat "as much or as little as they want, until they feel comfortably full".
Dietary Supplement: Casein (Cas) beverage
The preload is made from casein powder. The energy load of the preload is 105 kcal and has banana flavor and sweetener.

Placebo Comparator: Water
The water has the same banana flavor and sweetness to match the protein beverages. Participants receive the same amount of water like protein beverages - 200mL.
Dietary Supplement: Water
The preload is water acting as a control and contain the same banana flavor and sweetener to match the other three intervention - protein beverages.




Primary Outcome Measures :
  1. Baseline level and change in hunger ratings [ Time Frame: -5 minutes, 0 minute, 10 minutes, 20 minutes, 30 minutes, 50 minutes. ]
    A questionnaire assessing perceived hunger is completed at specific times points throughout each of the 1.5-h testing days. The questionnaire is a 100 mm VAS representing a horizontal line rating scale for each response. It asks: "How hungry do you feel right now?" with anchors of "not all" to "extremely." The range is 0 mm (min hunger) and 100 is (max hunger).

  2. Baseline level and change in fullness ratings [ Time Frame: -5 minutes, 0 minute, 10 minutes, 20 minutes, 30 minutes, 50 minutes. ]
    A questionnaire assessing perceived fullness is completed at specific times points throughout each of the 1.5-h testing days. The questionnaire is a 100 mm VAS representing a horizontal line rating scale for each response. It asks: "How full do you feel right now?" with anchors of "not all" to "extremely." The range is 0 mm (min fullness) and 100 is (max fullness).

  3. Baseline level and change in desire to eat ratings [ Time Frame: -5 minutes, 0 minute, 10 minutes, 20 minutes, 30 minutes, 50 minutes. ]
    A questionnaire assessing perceived desire to eat is completed at specific times points throughout each of the 1.5-h testing days. The questionnaire is a 100 mm VAS representing a horizontal line rating scale for each response. It asks: "How strong is your desire to eat right now?" with anchors of "not all" to "extremely." The range is 0 mm (min desire to eat) and 100 is (max desire to eat).

  4. Baseline level and change in prospective food consumption ratings [ Time Frame: -5 minutes, 0 minute, 10 minutes, 20 minutes, 30 minutes, 50 minutes. ]
    A questionnaire assessing perceived prospective food consumption is completed at specific time points throughout each of the 1.5-h testing days. The questionnaire is a 100 mm VAS representing a horizontal line rating scale for each response. It asks: "How much food do you think you could eat right now?" with anchors of "not all" to "extremely." The range is 0 mm (min prospective food consumption) and 100 is (max prospective food consumption.

  5. Baseline level and change in thirst ratings [ Time Frame: -5 minutes, 0 minute, 10 minutes, 20 minutes, 30 minutes, 50 minutes. ]
    A questionnaire assessing perceived thirst is completed at specific time points throughout each of the 1.5-h testing days. The questionnaire is a 100 mm VAS representing a horizontal line rating scale for each response. It asks: "How thirsty do you feel right now?" with anchors of "not all" to "extremely." The range is 0 mm (min thirst) and 100 is (max thirst).

  6. Baseline level and change in breakfast energy intake [ Time Frame: -5 minutes, 0 minute, 10 minutes, 20 minutes, 30 minutes, 50 minutes. ]
    The participants are provided with an ad libitum breakfast of cereals and milk, tea/coffee (at participant choice) and water. The amount of breakfast is provided (in grams) and is weighted prior to consumption and any remains are re-weighted after consumption. Energy consumed will be calculated. Participants are given 15 minutes for consuming the breakfast.

  7. Baseline level and change in salivary protein [ Time Frame: -5 minutes, 20 minutes, 50 minutes ]
    Saliva is collected on three time points on each visit. Salivary protein will be analyzed to determine the relationship between these components that affect oral lubrication and satiety and satiation.

  8. Baseline level and change in salivary amylase [ Time Frame: -5 minutes, 20 minutes, 50 minutes ]
    Saliva is collected on three time points on each visit. Salivary amylase will be analyzed to determine the relationship between these components that affect oral lubrication and satiety and satiation.

  9. Baseline level and change in salivary mucin [ Time Frame: -5 minutes, 20 minutes, 50 minutes, ]
    Saliva is collected on three time points on each visit. Salivary mucin will be analyzed to determine the relationship between these components that affect oral lubrication and satiety and satiation.


Secondary Outcome Measures :
  1. Liking and wanting of the preload using Visual Analogue Scale (VAS) [ Time Frame: Immediately after eating the preload. ]
    Liking and wanting of both the protein beverages and water are assessed through a 100 mm VAS scale where 0 means "not at all" and 100 means "extremely". Within the liking the ratings are taking on following attributes: the texture, flavor, sweetness and overall liking/pleasantness. The questions asked are: "How much did you like the texture of the product you have just consumed?", "How much did you like the flavor of the product you have just consumed?", How intense was the sweet taste of the product you have just consumed?", "How pleasant was the product you have just consumed? "with anchors from "not at all" to "extremely". And for the wanting assessment the question is: "How much did you want to consume the product you have just had?" with anchors from "not at all" to "extremely".



Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.


Layout table for eligibility information
Ages Eligible for Study:   18 Years to 55 Years   (Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Adults aged 18-55 years old
  • With a BMI between 18.5 - 27.99 kg/m²)
  • Generally healthy

Exclusion Criteria:

  • have any blood borne disease;
  • have type-1 or type-2 diabetes;
  • have liver and kidney disease;
  • have past history of gastrointestinal surgery;
  • are a smoker;
  • have oral infections/ diseases;
  • have chronic or acute health condition that may affect ability to sense, eat, digest, absorb or excrete food;
  • have a sensitive stomach (Irritable Bowel Stomach);
  • are currently using prescribed or non-prescribed medication;
  • are pregnant or lactating;
  • are suffering from an illness, feeling unwell, having fever, or cold or cough;
  • history of food allergy or intolerance;
  • are on any special diet or are taking protein and/or fibre supplements;
  • cannot tolerate protein beverages;
  • present any COVID related symptoms (high temperature, a new continuous cough, a loss or change to your smell or taste);
  • if you are self-isolating or if you leave with someone self-isolating or presenting COVID related symptoms.

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04868461


Locations
Layout table for location information
United Kingdom
University of Leeds Recruiting
Leeds, West Yorkshire, United Kingdom, LS2 9JT
Contact: Anwesha Sarkar, PhD    +441133432748    A.Sarkar@leeds.ac.uk   
Principal Investigator: Anwesha Sarkar, PhD         
Sub-Investigator: Ecaterina Stribitcaia, MSc         
Sub-Investigator: Graham Finlayson, PhD         
Sub-Investigator: John Blundell, PhD         
Sponsors and Collaborators
University of Leeds
Layout table for additonal information
Responsible Party: Anwesha Sarkar, Professor of Colloids and Surfaces, University of Leeds
ClinicalTrials.gov Identifier: NCT04868461    
Other Study ID Numbers: LUBSAT (18-049) - Protein
757993 ( Other Grant/Funding Number: European Research Council )
First Posted: May 3, 2021    Key Record Dates
Last Update Posted: May 3, 2021
Last Verified: April 2021
Individual Participant Data (IPD) Sharing Statement:
Plan to Share IPD: No

Layout table for additional information
Studies a U.S. FDA-regulated Drug Product: No
Studies a U.S. FDA-regulated Device Product: No
Keywords provided by Anwesha Sarkar, University of Leeds:
Lubrication
protein
satiety
appetite control
food intake
salivary biomarkers
Additional relevant MeSH terms:
Layout table for MeSH terms
Caseins
Chelating Agents
Sequestering Agents
Molecular Mechanisms of Pharmacological Action